Televisa Agrees to Buy AT&T's Stake in Sky Mexico Satellite TV Business
By Anthony Harrup
MEXICO CITY--Mexican cable and telecommunications company Grupo Televisa has agreed to buy AT&T's stake in its satellite television business Sky Mexico, with which Televisa will own 100% of the unit.
In a filing Wednesday with the Mexican stock exchange, Televisa said it will pay for the stake in 2027 and 2028.
Televisa said Sky Mexico Chief Executive Luis Malvido will step down on April 15 after two years in the position, and be replaced by Francisco Valim, who will also remain as chief executive of cable unit izzi.
In his extended role, Valim will be responsible for generating synergies and efficiencies for Televisa, the company added. Sky accounted for around 24% of Televisa's sales last year, and the cable unit for about 66%.
Televisa has around a 59% stake in Sky Mexico, which operates in Mexico, Central America and the Dominican Republic, and AT&T owns around 41% through DirecTV.
Terms of the stake acquisition weren't disclosed.
Write to Anthony Harrup at anthony.harrup@wsj.com
(END) Dow Jones Newswires
April 03, 2024 17:21 ET (21:21 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks